Katja Langen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Katja Langen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Minesh P. Mehta
Miami Cancer Institute, Baptist Health South Florida, Miami, FL
2 shared publications - Amish P. Shah
Orlando Hlth Canc Inst, Dept Radiat Oncol, Orlando, FL 32806 USA
1 shared publication - Benjamin J Waghorn
Department of Radiation Oncology, UF Health Cancer Center at Orlando Health, 1400 South Orange Avenue MP 730, Orlando, Florida 32806, USA
1 shared publication - Justin Rineer
Department of Radiation Oncology, Orlando Health Cancer Institute, 9900 W Colonial Drive, Ocoee, FL 34761, USA
1 shared publication - Michael David Chuong
Department of Radiation Oncology, Miami Cancer Institute, Miami, United States
1 shared publication - Sanford L. Meeks
Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, Florida
1 shared publication
Latest Publications
- 1 November 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (11) , 1204-1206
Proton Beam Therapy Basics
- 1 November 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (11) , 1204-1206
Proton Beam Therapy Basics
- 1 December 2014
- Vol. 12 (12) , 861-4
Is proton beam therapy better than standard radiation therapy? The available evidence points to benefits of proton beam therapy.
- 1 December 2014
- Vol. 12 (12) , 861-4
Is proton beam therapy better than standard radiation therapy? The available evidence points to benefits of proton beam therapy.
- Open Access
- 5 February 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 46
A margin-based analysis of the dosimetric impact of motion on step-and-shoot IMRT lung plans
Purpose: Intrafraction motion during step-and-shoot (SNS) IMRT is known to affect the target dosimetry by a combination of dose blurring and interplay effects. These effects are typically managed by adding a margin around the target. A quantitative analysis was performed, assessing the relationship between target motion, margin size, and target dosimetry with the goal of introducing new margin recipes. Methods: A computational algorithm was used to calculate 1,174 motion-encoded dose distributions and DVHs within the patient’s CT dataset. Sinusoidal motion tracks were used simulating intrafraction motion for nine lung tumor patients, each with multiple margin sizes. Results: D95% decreased by less than 3% when the maximum target displacement beyond the margin experienced motion less than 5 mm in the superior-inferior direction and 15 mm in the anterior-posterior direction. For target displacements greater than this, D95% decreased rapidly. Conclusions: Targets moving in excess of 5 mm outside the margin can cause significant changes to the target. D95% decreased by up to 20% with target motion 10 mm outside the margin, with underdosing primarily limited to the target periphery. Multi-fractionated treatments were found to exacerbate target under-coverage. Margins several millimeters smaller than the maximum target displacement provided acceptable motion protection, while also allowing for reduced normal tissue morbidity. PACS: 87.55.dk
- 5 February 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 46
Open AccessA margin-based analysis of the dosimetric impact of motion on step-and-shoot IMRT lung plans
Purpose: Intrafraction motion during step-and-shoot (SNS) IMRT is known to affect the target dosimetry by a combination of dose blurring and interplay effects. These effects are typically managed by adding a margin around the target. A quantitative analysis was performed, assessing the relationship between target motion, margin size, and target dosimetry with the goal of introducing new margin recipes. Methods: A computational algorithm was used to calculate 1,174 motion-encoded dose distributions and DVHs within the patient’s CT dataset. Sinusoidal motion tracks were used simulating intrafraction motion for nine lung tumor patients, each with multiple margin sizes. Results: D95% decreased by less than 3% when the maximum target displacement beyond the margin experienced motion less than 5 mm in the superior-inferior direction and 15 mm in the anterior-posterior direction. For target displacements greater than this, D95% decreased rapidly. Conclusions: Targets moving in excess of 5 mm outside the margin can cause significant changes to the target. D95% decreased by up to 20% with target motion 10 mm outside the margin, with underdosing primarily limited to the target periphery. Multi-fractionated treatments were found to exacerbate target under-coverage. Margins several millimeters smaller than the maximum target displacement provided acceptable motion protection, while also allowing for reduced normal tissue morbidity. PACS: 87.55.dk